1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
    Meeting Abstract

    Dockery, L.; Priebe, A.; Duska, L.; Green, A.; Mathews, C.; Musa, F.; O'Malley, D.; Puechl, A.; Ding, L.; Schmid, A.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • First-in-human phase 1/2 study of ubamatamab, a MUC16XCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer
    Meeting Abstract

    Moore, K.; Bouberhan, S.; Hamilton, E.; Liu, J. Y.; O'Cearbhaill, R.; O'Malley, D.; Papadimitriou, K.; Schröder, D.; Van Nieuwenhuysen, E.; Yoo, S. Y.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Radiation quality and workflow in NRG GY017: Anti PD-L1 (atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer
    Meeting Abstract

    Mayadev, J.; Deng, W.; Zamarin, D.; Lankes, H.; Kim, H.; Chino, J.; Banberry, B.; Sherry, N.; Ghamande, S.; Ferguson, C.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes associated with postoperative chemotherapy following pelvic exenteration for recurrent or persistent gynecologic malignancies
    Meeting Abstract

    Zammarrelli, B.; Saini, A.; Rios-Doria, E.; Yeoshoua, E.; Jewell, E.; Tew, W.; Abu-Rustum, N.; Leitao, M.; Sonoda, Y.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Genomic evolution of uterine leiomyosarcoma: a study of serial recurrences
    Meeting Abstract

    Sia, T.; Miller, K.; Brown, D.; Selenica, P.; Paula, A. D.; Abu-Rustum, N.; Leitao, M.; Chiang, S.; Weigelt, B.; Hensley, M.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Molecular characterization of stage I, grade 3 endometrioid endometrial cancer
    Meeting Abstract

    Zammarrelli, B.; Paula, A. D.; Manning-Geist, B.; Kim, S.; Leitao, M.; Abu-Rustum, N.; Makker, V.; Ellenson, L.; Mueller, J.; Weigelt, B.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • The genomic landscape of distant metastatic endometrial cancer
    Meeting Abstract

    Zammarrelli, B.; Nandakumar, S.; Kertowidjojo, E.; Nguygen, B.; Paula, A. D.; Rios-Doria, E.; Smith, S.; Momeni-Boroujeni, A.; Aghajanian, C.; Mueller, J.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • A randomized, phase II/III study of pegylated-liposomal-doxorubicin and atezolizumab (IND #134427) versus pegylated-liposomal-doxorubicin, bevacizumab and atezolizumab versus pegylated-liposomal-doxorubicin and bevacizumab in platinum-resistant ovarian cancer (NRG-GY009)
    Meeting Abstract

    O'Cearbhaill, R.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; Mathews, C.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: Results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study
    Meeting Abstract

    Lee, J. Y.; Makker, V.; Manso, L.; González-Martín, A.; Lugowska, I.; Lorusso, D.; Banerjee, S.; Liao, J.; Lu, C. H.; Prasongsook, N.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: Long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Scambia, G.; Vergote, I.; Hamilton, E.; Fidalgo, J. P.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save